The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial

The anti-inflammatory agent, mesalamine (5-aminosalicylic acid) has been shown to decrease mucosal inflammation in ulcerative colitis. The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal immune activation and microbial translocation (MT), has not been established in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Somsouk, Ma, Dunham, Richard M., Cohen, Michelle, Albright, Rebecca, Abdel-Mohsen, Mohamed, Liegler, Teri, Lifson, Jeffrey, Piatak, Michael, Gorelick, Robert, Huang, Yong, Wu, Yuaner, Hsue, Priscilla Y., Martin, Jeffrey N., Deeks, Steven G., McCune, Joseph M., Hunt, Peter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283685/
https://www.ncbi.nlm.nih.gov/pubmed/25545673
http://dx.doi.org/10.1371/journal.pone.0116306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283685/
https://www.ncbi.nlm.nih.gov/pubmed/25545673
http://dx.doi.org/10.1371/journal.pone.0116306

Ejemplares similares